Novavax NVAX Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novavax NVAX

NVAX 7.705

+2.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jack Hartmann who wrote (1)	3/24/2002 7:02:53 AM
From: Art M	Read Replies (1) of 166

The number of women who were compliant in the study amazes me. One of the highest response rates I have ever seen in a phase III study. And the number of women that would prefer the cream rather than patches or pills is overwhelming. I found a link of the presentation of the SSB conference at: veracast.com It is very informative. Did not realize NVAX had so many drug candidates that are so advanced in Phase II/III tests. Of course, I never heard of the company until Friday. With product launch in May and revenues coming in late summer and early fall, this could make one hell of a run. Got in on the close Friday, hoping for a USA Today article on Monday, but I think I will take a much larger position, market willing, on Monday. Thanks for starting this thread Jack. Art

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next